CIK 0001347178
- Accelerated filer
Vanda Pharmaceuticals Inc.
Sign in to watch- Ticker
- VNDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 030491827
- Phone
- +1 202-734-3400
- Business address
- 2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
- Open-market buys, last 90 days
- $38,094
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$38,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2013-02-14 | Kelly James Patrick SVP, CFO, Sec & Treasurer | Exercise or conversion | +12,500 | 25,080 | ||
| 2013-02-14 | Kelly James Patrick SVP, CFO, Sec & Treasurer | Exercise or conversion | +4,687 | 29,767 | ||
| 2013-02-14 | Kelly James Patrick SVP, CFO, Sec & Treasurer | Shares withheld for taxes | −6,978 | $3.95 | $28K | 22,789 |
| 2013-02-14 | Kelly James Patrick SVP, CFO, Sec & Treasurer | Exercise or conversion · Restricted Stock Unit | −12,500 | 25,000 | ||
| 2013-02-14 | Kelly James Patrick SVP, CFO, Sec & Treasurer | Exercise or conversion · Restricted Stock Unit | −4,687 | 14,063 | ||
| 2012-12-07 | Repella Robert SVP & Cheif Commercial Officer | Grant or award · Employee Stock Option (Right to Buy) | +56,250 | 56,250 | ||
| 2012-12-07 | Repella Robert SVP & Cheif Commercial Officer | Grant or award · Restricted Stock Unit | +18,750 | 18,750 | ||
| 2012-12-07 | Kelly James Patrick SVP, CFO, Sec & Treasurer | Grant or award · Employee Stock Option (Right to Buy) | +56,250 | 56,250 | ||
| 2012-12-07 | Kelly James Patrick SVP, CFO, Sec & Treasurer | Grant or award · Restricted Stock Unit | +18,750 | 18,750 | ||
| 2012-12-07 | Polymeropoulos Mihael Hristos President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2012-12-07 | Polymeropoulos Mihael Hristos President and CEO | Grant or award · Restricted Stock Unit | +50,000 | 50,000 | ||
| 2012-06-14 | Watkins Thomas Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2012-06-14 | PIEN HOWARD H Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2012-06-14 | MILANO VINCENT Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2012-06-14 | Galson Steven K Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2012-06-14 | DUGAN RICHARD W Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2012-06-14 | COLA MICHAEL F Director | Grant or award · Stock Option (Right to Buy) | +35,000 | 35,000 | ||
| 2012-02-16 | Feeney John Joseph SVP & Chief Medical Officer | Exercise or conversion | +7,500 | 12,015 | ||
| 2012-02-16 | Feeney John Joseph SVP & Chief Medical Officer | Exercise or conversion | +4,687 | 16,702 | ||
| 2012-02-16 | Feeney John Joseph SVP & Chief Medical Officer | Sale | −4,760 | $4.65 | $22K | 11,942 |
Page 35 of 36 · 717 trades